Replies to post #5779 on Pluristem Therapeutics Inc (PSTI)

[bluehorsesho]

just being real, they don't have to be threatened by...

listing requirements.....large OS will be another trigger....

just keeping it balanced.....imhop

many companies above $1 do a RS to reduce OS......just saying time for the dynamic duo to fulfill their promises or out the door they should go.....imhop

remember many funds and institution can't buy stocks under $5.........150 million shares with a 1-10 RS takes it to 15 mill and lets say the common is at $1.05 before RS........hmmmmmmm !!

don't let it fool you, they would do another RS in a heart beat to keep things going with high pay and big bonuses....and big promises.....remember without the ARS contract they will be 2-4 years from any revenue.....imhop

we all have our opinions.............

[Scott999]

Hey I think everyone flip flops each and every day. I can hourly sometimes. Those bonuses ate at me for a while, then I'm trying to think positive that they were hopefully deserved.

Obviously the ARS is our most likely catalyst. The ARS comparison between Neupogen and PLX was eased a lot when I saw Neupogen used 100% and 80% males in their trials. Unfair advantage as it was only the female NPH's that died with PLX. Out numbers would most likely been much higher using the same gender ratios they did. Looking forward to see what they are going to release later this month. Peeves me off that we have to wait that long. But hoping there is a reason for that.

Like Blue says, a couple more months will be telling. Something is brewing imo. Only thing is if it was big in nature, you would have thought something would get leaked somewhere. Hoping to see a significant uptick in volume, along with a little price gain in the next couple of weeks.